Drug Trial Radar · NCT02579096
CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
Last checked: Nov 20, 2026Latest source record: Mar 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
950
Actual
Start
Mar 6, 2017
Primary completion
Feb 1, 2021
Study completion Apr 15, 2021
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- First posted
- Oct 19, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial will compare two effective therapies, allopurinol and febuxostat, to lower serum uric acid and therefore prevent further gout attacks. These therapies have never been compared at appropriate doses. Further, they will be studied in patients with kidney disease for the first time.
Conditions
- Gout
- Chronic Kidney Diseases
Interventions
allopurinol capsule, 100-800 mg by mouth once dailyDrug
Patients will be up-titrated up to the dose required to reach target uric acid levels.
febuxostat tablet 40-120 mg by mouth once dailyDrug
Patients will be up-titrated to the dose required to reach target uric acid levels.
Placebo, vehicle control (febuxostat-shaped)Drug
Placebo tablets resembling febuxostat will be given with allopurinol.
Placebo, vehicle control (allopurinol-shaped)Drug
Placebo capsules resembling allopurinol will be given with febuxostat.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Experiencing ≥ 1 Gout Flare During Phase 3Time frame: Phase III of the study (weeks 49-72 of study duration)
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
VA Loma Linda Healthcare System, Loma Linda, CA
Loma Linda, California
VA San Diego Healthcare System, San Diego, CA
San Diego, California
San Francisco VA Medical Center, San Francisco, CA
San Francisco, California
Miami VA Healthcare System, Miami, FL
Miami, Florida
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota
Mayo Clinic Rochester MN ? RAIN 1
Rochester, Minnesota
Kansas City VA Medical Center, Kansas City, MO
Kansas City, Missouri
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Omaha, Nebraska
University of Nebraska Medical Center ? RAIN 5
Omaha, Nebraska
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
New York, New York
Asheville VA Medical Center, Asheville, NC
Asheville, North Carolina
Sanford Bismarck Medical Center ? RAIN 2
Bismarck, North Dakota
Cincinnati VA Medical Center, Cincinnati, OH
Cincinnati, Ohio
VA Portland Health Care System, Portland, OR
Portland, Oregon
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania
Yankton Medical Clinic ? RAIN 3
Yankton, South Dakota
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Dallas, Texas
VA Salt Lake City Health Care System, Salt Lake City, UT
Salt Lake City, Utah
White River Junction VA Medical Center, White River Junction, VT
White River Junction, Vermont
Salem VA Medical Center, Salem, VA
Salem, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.